Skip to main content


GRObio is actively pursuing a range of partnering opportunities to expand our platform and to access novel application spaces, including collaborations that will:

  • Accelerate the expansion and development of GRObio’s current pipeline of programs
  • Extend ProGly™ and other NSAA chemistries into new disease areas and therapeutic modalities
  • Broaden the universe of NSAA chemistries and applications of our GRO platform

For more information, please contact our Business Development team at